The development of miniaturized flow platforms would enable efficient and selective synthesis of drug and lead molecules by rapidly exploring synthetic methodologies and screening for optimal ...
The types and numbers of components in end-of-life (EOL) products are often uncertain during remanufacturing, leading to low disassembly efficiencies for traditional remanufacturing disassembly lines.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results